These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9643364)

  • 41. The C-terminus of lipoprotein lipase is essential for biological function but contains no domain for glycosylphosphatidylinositol anchoring.
    Bruin T; Groot NB; Jansen J; Kastelein JJ
    Eur J Biochem; 1994 May; 221(3):1019-25. PubMed ID: 8181457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of lipoprotein lipase with heparin.
    Oka K; Wang-Iverson P; Paterniti JR; Brown WV
    Ann N Y Acad Sci; 1989; 556():173-80. PubMed ID: 2735657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production.
    Obunike JC; Pillarisetti S; Paka L; Kako Y; Butteri MJ; Ho YY; Wagner WD; Yamada N; Mazzone T; Deckelbaum RJ; Goldberg IJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):111-8. PubMed ID: 10634807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).
    Reimund M; Larsson M; Kovrov O; Kasvandik S; Olivecrona G; Lookene A
    J Biol Chem; 2015 May; 290(22):13919-34. PubMed ID: 25873395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of N-glycosylation at asparagine 43 in human lipoprotein lipase induces its accumulation in the rough endoplasmic reticulum and alters this cellular compartment.
    Buscá R; Pujana MA; Pognonec P; Auwerx J; Deeb SS; Reina M; Vilaró S
    J Lipid Res; 1995 May; 36(5):939-51. PubMed ID: 7658166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures.
    Sehayek E; Olivecrona T; Bengtsson-Olivecrona G; Vlodavsky I; Levkovitz H; Avner R; Eisenberg S
    Atherosclerosis; 1995 Apr; 114(1):1-8. PubMed ID: 7605368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
    Ancsin JB; Kisilevsky R
    J Biol Chem; 1999 Mar; 274(11):7172-81. PubMed ID: 10066777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional analyses of human apolipoprotein CII by site-directed mutagenesis: identification of residues important for activation of lipoprotein lipase.
    Shen Y; Lookene A; Nilsson S; Olivecrona G
    J Biol Chem; 2002 Feb; 277(6):4334-42. PubMed ID: 11719505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia.
    Previato L; Guardamagna O; Dugi KA; Ronan R; Talley GD; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 1994 Sep; 35(9):1552-60. PubMed ID: 7806969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10).
    Campanella GS; Lee EM; Sun J; Luster AD
    J Biol Chem; 2003 May; 278(19):17066-74. PubMed ID: 12571234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties.
    Lookene A; Groot NB; Kastelein JJ; Olivecrona G; Bruin T
    J Biol Chem; 1997 Jan; 272(2):766-72. PubMed ID: 8995362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
    Park K; Verchere CB
    J Biol Chem; 2001 May; 276(20):16611-6. PubMed ID: 11145957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of substitutions of glycine and asparagine for serine132 on activity and binding of human lipoprotein lipase to very low density lipoproteins.
    Tashiro J; Kobayashi J; Shirai K; Saito Y; Fukamachi I; Hashimoto H; Nishida T; Shibui T; Morimoto Y; Yoshida S
    FEBS Lett; 1992 Feb; 298(1):36-8. PubMed ID: 1544420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X.
    Lethias C; Elefteriou F; Parsiegla G; Exposito JY; Garrone R
    J Biol Chem; 2001 May; 276(19):16432-8. PubMed ID: 11278641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycosylation, dimerization, and heparin affinity of lipoprotein lipase in 3T3-L1 adipocytes.
    Park JW; Oh MS; Yang JY; Park BH; Rho HW; Lim SN; Jhee EC; Kim HR
    Biochim Biophys Acta; 1995 Jan; 1254(1):45-50. PubMed ID: 7811745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysis.
    Ma YH; Bruin T; Tuzgol S; Wilson BI; Roederer G; Liu MS; Davignon J; Kastelein JJ; Brunzell JD; Hayden MR
    J Biol Chem; 1992 Jan; 267(3):1918-23. PubMed ID: 1730727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unraveling the amino acid sequence crucial for heparin binding to collagen V.
    Delacoux F; Fichard A; Cogne S; Garrone R; Ruggiero F
    J Biol Chem; 2000 Sep; 275(38):29377-82. PubMed ID: 10862775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability.
    Keiper T; Schneider JG; Dugi KA
    J Lipid Res; 2001 Aug; 42(8):1180-6. PubMed ID: 11483618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates.
    Ben-Zeev O; Mao HZ; Doolittle MH
    J Biol Chem; 2002 Mar; 277(12):10727-38. PubMed ID: 11796709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
    Yang WS; Nevin DN; Peng R; Brunzell JD; Deeb SS
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4462-6. PubMed ID: 7753827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.